This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Biomerieux, Inc.. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Marine Steidel: Innovator in Dengue Virus Detection
Introduction
Marine Steidel is a notable inventor based in Fellering, France. He has made significant contributions to the field of medical diagnostics, particularly in the detection of viral infections. His innovative approach has led to the development of a patented process that enhances the early detection of dengue virus infections.
Latest Patents
Marine Steidel holds a patent for a process titled "Process for the detection and early serotyping of the dengue virus." This patent outlines a method for in vitro detection of dengue virus infection in individuals. The process involves several steps, including contacting a blood sample with a ligand specific to the NS1 protein of the dengue virus. If the NS1 protein is present, it is captured and detected through mass spectrometry. This method allows for timely diagnosis and intervention for those infected with the dengue virus. He has 1 patent to his name.
Career Highlights
Marine Steidel is currently associated with bioMérieux, Inc., a company renowned for its expertise in in vitro diagnostics. His work at bioMérieux has positioned him at the forefront of innovative medical solutions. His contributions are vital in improving diagnostic accuracy and patient outcomes in infectious diseases.
Collaborations
Marine collaborates with talented professionals in his field, including Frederic Bedin and Sandrine Busseret. Their combined expertise fosters a collaborative environment that drives innovation and enhances research outcomes.
Conclusion
Marine Steidel's work in the detection of the dengue virus exemplifies the impact of innovation in medical diagnostics. His patented process not only advances the field but also contributes to better health outcomes for individuals at risk of dengue virus infection.